Intracellular transcriptional regulators and extracellular signaling pathways together regulate the allocation of cell fates during development, but how their molecular activities are integrated to establish the correct proportions of cells with particular fates is not known. Here we study this question in the context of the decision between the epiblast (Epi) and the primitive endoderm (PrE) fate that occurs in the mammalian preimplantation embryo. Using an embryonic stem cell (ESC) model, we discover two successive functions of FGF/MAPK signaling in this decision. First, the pathway needs to be inhibited to make the PrE-like gene expression program accessible for activation by GATA transcription factors in ESCs. In a second step, MAPK signaling levels determine the threshold concentration of GATA factors required for PrE-like differentiation, and thereby control the proportion of cells differentiating along this lineage. Our findings can be explained by a simple mutual repression circuit modulated by FGF/MAPK signaling. This might be a general network architecture to integrate the activity of signal transduction pathways and transcriptional regulators, and serve to balance proportions of cell fates in several contexts.
To ensure the faithful development of multicellular organisms, cell fate decisions in populations of undifferentiated cells have to be tightly balanced. It is now well established that transcriptional networks and extracellular signals together control these decisions, but how their interactions determine the proportions of cells differentiating along particular lineages is often not known. This question is of particular importance in one of the first cell fate decisions in the mammalian preimplantation embryo, where a small number of inner cell mass (ICM) cells have to reliably populate both the epiblast (Epi) lineage that will give rise to the embryo proper, as well as the primitive endoderm (PrE) lineage, which differentiates into tissues that function in patterning and nutrient supply of the embryo (Rossant and Tam, 2009). The factors underlying this fate decision have been studied in embryos and embryonic stem cells (ESCs) (Cho et al., 2012; Fujikura et al., 2002; Shimosato et al., 2007), clonal derivatives of ICM cells that are biased towards the Epi fate but harbor a latent PrE differentiation potential (Beddington and Robertson, 1989; Morgani et al., 2013). Mutant analysis indicates that a transcriptional network centered on the transcription factor NANOG marks and defines the Epi fate (Chambers et al., 2007; Frankenberg et al., 2011), whereas a network centered on GATA transcription factors underlies the PrE fate (Bessonnard et al., 2014; Schrode et al., 2014). NANOG and GATA6 are co-expressed in early ICM cells, but their expression patterns become mutually exclusive as cells commit to specific fates (Plusa et al., 2008), suggesting mutually repressive interactions between the two programs (Frankenberg et al., 2011; Schrode et al., 2014). Studies using genetic mutants and pharmacological inhibitors have furthermore shown that the FGF/MAPK signaling pathway promotes the PrE fate at the expense of the Epi fate in embryos (Kang et al., 2012; Nichols et al., 2009; Yamanaka et al., 2010), and that it is required for PrE-like differentiation of ESCs (Cho et al., 2012). How the activities of the transcriptional networks are integrated with the activity of the FGF/MAPK signaling pathway, and how these inputs together control the proportion of cells differentiating along either lineage has not been systematically investigated.
Recently, a mathematical model for the decision between the Epi and the PrE fate has been proposed (Bessonnard et al., 2014), in which Nanog and Gata6 repress each other, and reinforce their own expression through direct positive feedback. This defines a dynamic system with three stable states in which cells either express GATA6 or NANOG alone, or co-express the two markers. In this model, FGF/MAPK signaling both promotes GATA6 expression and inhibits NANOG expression, and differences in FGF/MAPK signaling between cells have been proposed to underlie fate choice from the co-expression state (Bessonnard et al., 2014). Although this model is consistent with static phenotypes of wild-type embryos and genetic mutants, the gene expression dynamics proposed have not directly been tested. It is also not clear whether all proposed links are required to explain the behavior of the genetic circuit underlying this cell fate decision, and which one of the two inputs into the system – signaling or transcription factor activity – most influences the fate decision. Addressing these open questions requires quantitative modulation of the inputs into the genetic circuit regulating fate choice, and following its dynamics in single cells in real time. Here, we achieve this by transiently expressing fluorescently tagged GATA factors in ESCs carrying live reporters for the Epi and the PrE fate. This allows us to recreate a state of co-expression of Epi and PrE determinants akin to the state of ICM cells in the embryo, and to follow the resolution of this state in real time. We find that cells rapidly exit the co-expression state towards one of two mutually exclusive states, i.e. the system is bistable. PrE-like differentiation occurs in cells exposed to GATA factor levels above a threshold, and the function of FGF/MAPK signaling is to set this threshold dose. This provides a mechanism through which both transcription factor activity and signaling can tune the proportions of cells with specific fates. Recapitulating the dynamic behavior of the circuit in silico only requires mutual repression between the transcriptional networks underlying the Epi and the PrE fates without any positive feedback loops, and a single repressive input of MAPK signaling on the Epi-specific program. This data-based model for the Epi-versus-PrE fate decision, much simpler than previously proposed models, will serve as a basis to guide further experimental and theoretical exploration of this crucial fate decision of mammalian embryogenesis. Furthermore, our finding that FGF/MAPK signaling can balance the proportions of alternative fates in cell populations by setting the response threshold of a regulatory network to a transcription factor input is a novel principle for this signaling pathway which might be relevant in developing tissues beyond the ICM.
An ESC model system to investigate PrE-like fate choice in culture
To model in culture the transition from GATA6/NANOG co-expression to mutually exclusive expression of Epi and PrE markers that characterizes the Epi-versus-PrE fate decision (Plusa et al., 2008), we used a doxycycline-inducible system to transiently express GATA6-FLAG in ESCs (Beard et al., 2006; Mulvey et al., 2015; Wamaitha et al., 2015) (Fig. 1A). Individual cells co-expressed inducible GATA6-FLAG and endogenous NANOG protein after a 6 h doxycycline pulse (Fig. 1B). Twenty-four hours after doxycycline removal, the cells had degraded the exogenous GATA6-FLAG, but a subset now stained positive for the endogenous PrE marker GATA4 (Fig. 1C). Virtually all GATA4-positive cells were negative for NANOG staining, suggesting that following GATA6/NANOG co-expression, ESCs transition to one of two mutually exclusive states, marked by the expression of Epi and PrE markers, respectively. This is similar to the behavior of ICM cells, and suggests that a previously reported stable state of co-expression of NANOG and endogenous GATA factors (Bessonnard et al., 2014) is not accessible in our system.
Consistent with previous studies (Fujikura et al., 2002; Mulvey et al., 2015; Shimosato et al., 2007), we found that transient expression of doxycycline-inducible GATA4-FLAG instead of GATA6-FLAG led to the same expression pattern of endogenous GATA factors, but doubled the proportion of differentiating cells (Fig. 1D-F, Fig. S1). This led us to induce PrE-like differentiation with GATA4 and to use endogenous GATA6 expression to monitor the differentiation event in all following experiments. Furthermore, we tagged the inducible GATA4 protein with an mCherry fluorescent protein. This did not compromise the activity of the fusion protein to induce PrE-like differentiation (Fig. S2), and allowed us to follow the heterogeneous expression of the doxycycline-induced transgene in individual live cells.
ESC culture conditions affect the expression of endogenous PrE markers following a GATA4-mCherry pulse
For an induced transcription factor to trigger a specific differentiation program, this program needs to be molecularly accessible. We therefore set out to determine culture conditions for which transient GATA4-mCherry expression led to efficient expression of endogenous GATA6. In the presence of feeders and 15% serum, a 6 h pulse of GATA4-mCherry expression resulted in ∼10% GATA6-positive cells 24 h later. This proportion dropped to ∼1.5% GATA6-positive cells when cells were cultured without feeders in 10% serum (Fig. S3A,B), even though GATA4-mCherry was efficiently induced in both conditions (Fig. S3C) and cells were positive for the pluripotency marker NANOG (Fig. S3A). Next, we pre-cultured cells in 2i+leukemia inhibitory factor (LIF), a condition reported to promote extraembryonic differentiation potential (Morgani et al., 2013), before simultaneous addition of doxycycline and transfer into serum-containing medium. This increased the proportion of GATA6-positive cells induced by a 6 h doxycycline pulse from 11.3±1.8% (mean±s.d.) for 1 day of pre-culture in 2i+LIF to 51.7±9.8% for 7 days of pre-culture (Fig. 2A-C). Because the duration of the pre-culture in 2i+LIF also affected the levels of GATA4-mCherry expression induced by doxycycline (Fig. S4A), we determined the ratio between the fraction of GATA6-positive cells one day after a 6 h doxycycline pulse and the fraction of GATA4-mCherry-positive cells immediately after the pulse as a measure for the efficiency of PrE-like differentiation. This ratio plateaus at ∼55% after 3 days of pre-culture in 2i+LIF (Fig. 2C).
To assess the influence of the components of 2i+LIF, we removed each of them from the complete 2i+LIF medium or added them individually to serum-containing medium during 3 days of pre-culture. All conditions led to an increase in the percentage of GATA6-positive cells 24 h after a 6 h doxycycline pulse, albeit to different degrees (Fig. 2D-F). The largest proportion of GATA6-positive cells was obtained for pre-culture in serum, LIF and the MEK inhibitor PD0325901 (PD03) (Fig. 2F, Fig. S4B). We conclude that inhibition of MAPK signaling prior to the induced expression of GATA factors efficiently restores PrE-like differentiation potential in ESCs. For all following experiments, we therefore pre-cultured cells for 3 days in the presence of PD03 in medium containing serum and LIF.
Transient expression of exogenous GATA4-mCherry induces stable PrE-like differentiation
Having established an experimental regime which induced PrE-like differentiation in ESCs with an efficiency mimicking PrE differentiation in the embryo (Schrode et al., 2014), we next wanted to investigate the stability of the GATA6-positive state and the dynamics with which it evolved. To this end we created a Gata6:H2B-Venus transcriptional reporter (Freyer et al., 2015) in cells carrying the inducible GATA4-mCherry transgene, which faithfully recapitulated GATA6 protein expression between one and three days after the doxycycline pulse (Fig. 3A,B; Fig. S5). Transient GATA4-mCherry expression led to a characteristic bimodal distribution of Gata6:H2B-Venus expression (Fig. 3C). Venus expression levels of cells in the Venushigh peak were constant between 32 h and 80 h after the end of a 6 h doxycycline pulse (Fig. 3C,D). Furthermore, whereas cells with intermediate Venus levels progressively disappeared from the distribution (Fig. 3C), cells sorted for highest Venus expression levels maintained their fluorescence intensity over several cell divisions for 48 h (Fig. 3E). Together, these findings indicate that strong reporter expression marks a stable state in individual cells, and suggests that the decrease in the proportion of Venushigh cells is mainly a result of reduced proliferation of the Venushigh cells compared with the Venuslow cells, although we cannot rule out that undifferentiated cells induce reversion of Venus-positive cells in unsorted populations. Finally, to follow the dynamics of Gata6:H2B-Venus expression over time in individual cells, we performed time-lapse microscopy and tracking of reporter cells (Movie 1). Clustering of traces according to H2B-Venus expression levels identified two distinct classes of cells (Fig. 3F, Fig. S6). Expression traces corresponding to these two classes were separated throughout the experiment. Whereas some cells with intermediate Venus levels reverted to a Venus-negative state, consistent with the depletion of this population that we had observed by flow cytometry, cells with highest Venus expression remained in this class throughout the experiment (Fig. 3F). These results show that a transient GATA4-mCherry input elicits stable expression of one of two mutually exclusive expression programs, suggesting the system behaves as an irreversible switch with two stable states.
A threshold level of GATA4-mCherry controls PrE-like differentiation
We then asked whether the flipping of the bistable switch that we had identified depended on the expression levels of the doxycycline-induced GATA4-mCherry protein. Varying the duration and levels of GATA4-mCherry exposure by applying doxycycline pulses of different lengths (Fig. S7) smoothly tuned the proportion of Gata6:H2B-Venushigh cells (Fig. 4A,B). Furthermore, we observed more differentiating GATA6-positive cells and fewer undifferentiated NANOG-positive cells in populations that had been sorted for high GATA4-mCherry expression levels immediately after the doxycycline pulse compared with populations sorted for low GATA4-mCherry expression (Fig. 4C,D; Fig. S8). Together, this suggests that GATA4-mCherry expression levels control the proportion of cells undergoing PrE-like differentiation.
To correlate GATA4-mCherry input levels more precisely with subsequent fate choice in single cells, we performed time-lapse imaging of GATA4-mCherry-inducible cells during and after a doxycycline pulse, followed by immunostaining for NANOG and GATA6 (Movie 2; Fig. S9A,B). We found that most cells with GATA6-positive progeny had experienced higher GATA4-mCherry expression levels than cells with NANOG-positive progeny (purple and green datapoints in Fig. 4E,F and in Fig. S9C). We used receiver operating characteristics (ROC) analysis (Fawcett, 2006) (for details see the supplementary materials and methods) to assess how well the two classes of cells could be separated by a threshold value of GATA4-mCherry expression. Plotting the ratio of correctly and incorrectly separated events over the total number of cells (true positive ratio, TPR; false positive ratio, FPR) for varying threshold values gives a characteristic curve for a single time-point (Fig. 4G); the larger the area under this curve (AUC), the better the differentiation outcomes can be separated or predicted from GATA4-mCherry expression levels. The AUC increased quickly upon doxycycline addition and reached a plateau between 0.8 and 0.9 after ∼3 h (Fig. 4H). Similar results were obtained when we used cumulative instead of instantaneous GATA4-mCherry expression measurements (not shown), suggesting that non-systematic measurement errors are not a major limitation of predictive power. The optimal prediction threshold that maximizes the difference between TPR and FPR tracked the expression dynamics of the GATA4-mCherry protein throughout the experiment (black line in Fig. 4E and Fig. S10A,B). Using this threshold, more than 80% of all fate decisions could be correctly predicted based on the GATA4-mCherry classifier (Fig. S10C). This predictability of fate choice by GATA4-mCherry expression levels suggests this transcription factor is a dominant input into the decision in ESCs.
FGF/MAPK signaling modulates the proportion of cells with PrE-like differentiation
In the mouse embryo, both GATA factors and FGF/MAPK signaling are required to establish PrE identity. Having shown above that inhibiting MAPK signaling prior to doxycycline-induced GATA expression increases the proportion of cells with PrE-like differentiation, we next wanted to test how MAPK signaling affected the decision to embark on PrE-like differentiation during and after the GATA pulse. MAPK activity required for PrE-like differentiation was almost completely saturated in serum-free medium, possibly through autocrine FGF signaling (Figs S11, S12), prompting us to tune the levels of Erk phosphorylation following removal of the pre-culture medium with subsaturating doses of PD03 (Fig. 5A). Partial inhibition of MAPK signaling during the 6 h doxycycline pulse and the 24 h chase period reduced the fraction of GATA6-positive cells, but not the expression levels of GATA6 in individual differentiated cells (Fig. 5B,C), with a quasi-linear relationship between the level of Erk phosphorylation and the percentage of differentiating cells (Fig. 5D). We obtained similar results using the FGF receptor inhibitor PD173074 (Fig. S12), indicating that most of the MAPK activity relevant for PrE-like differentiation of ESCs is triggered by FGF ligands, consistent with literature reports (Kunath et al., 2007). FGF/MAPK signaling levels therefore control the fraction of cells that embark on the PrE-like differentiation path.
To investigate how partial MEK inhibition affected the GATA4-mCherry threshold required for PrE-like differentiation, we performed time-lapse imaging and cell tracking for maximal and reduced MAPK signaling in parallel (Fig. 5E,F), using a PD03 concentration that led to a significant reduction of the number of differentiating cells without inducing cell death (Movie 3). ROC analysis gave similar AUC values for both conditions, indicating that differentiation can be predicted based on GATA4-mCherry expression levels with similar confidence at different signaling levels (Fig. 5G). However, the optimal prediction threshold was consistently increased upon partial MEK inhibition (Fig. 5F,H). We conclude that MAPK signaling levels set the GATA4-mCherry threshold dose required to trigger differentiation.
We noticed that the distribution of GATA4-mCherry expression levels in differentiating and non-differentiating cells changed upon partial inhibition of signaling (Fig. 5E,F). In addition to setting the transcription factor threshold dose, partial MEK inhibition therefore appears to modulate heterogeneities in the population that affect PrE-like differentiation.
A simple mutual repression circuit recapitulates the experimentally observed gene expression dynamics
To assess the dynamics of the endogenous circuit described by this model we plotted the nullclines dG/dt=0 and dN/dt=0 for the specific set of parameters used. Two of the three equilibrium states defined by the intersections of the nullclines are stable and correspond to the fully differentiated GATA-positive and the undifferentiated NANOG-positive state, respectively (Fig. 6B). A boundary in the phase space (dashed line in Fig. 6B) separates the combinations of GATA and NANOG levels which will evolve into the fully differentiated GATA-positive state from those that lead to the undifferentiated NANOG-positive state. To induce PrE-like differentiation, the exogenous GATA input has to exceed the threshold required to move cells across this boundary by sufficiently repressing NANOG and allowing for endogenous GATA expression. For the chosen parameter set, simulated time traces of individual cells closely resembled the experimentally observed expression dynamics of the endogenous Gata6 gene (Fig. 6C, compare with Fig. 3F), and exogenous GATA4-mCherry (Fig. 6D, compare with Fig. 4E), suggesting this simple mutual repression circuit is sufficient to capture essential dynamics of the experimental system.
To further test the model, we compared the dynamics of NANOG expression in silico and in vivo. In model simulations, NANOG expression levels first decreased rapidly in all cells from the initial conditions chosen to represent the effects of the pre-culture regime towards lower steady state levels, before differences in NANOG expression levels in differentiating and non-differentiating cells became apparent (Fig. 6E). To monitor NANOG expression dynamics experimentally, we integrated a previously described NANOG-Venus translational fusion reporter (Filipczyk et al., 2013) into the inducible cell line. Following transient GATA4-mCherry expression, this reporter showed expression dynamics that were in close agreement with the model simulations, further supporting the idea that a simple mutual repression circuit is sufficient to capture the dynamics of the system.
Inhibition of the Epi program by MAPK signaling controls the proportion of cells with PrE-like differentiation
To pinpoint the main mechanism by which FGF/MAPK signaling controls the fraction of cells with PrE-like differentiation, we considered two simple extensions of the model, one in which FGF/MAPK signaling promotes expression of the PrE program (Fig. 7A), and an alternative model in which signaling inhibits the Epi program (Fig. 7B). In both cases a reduction of signaling led to a simulated increase in the number of cells in the NANOG-positive peak and a decrease of cells in the GATA-positive peak (Fig. 7A,B, middle). However, expression levels in the respective positive peaks changed in distinct ways depending on the type of signaling input (Fig. 7A,B, middle and bottom). Estimating changes in GATA6 and NANOG expression levels upon partial MEK inhibition from flow cytometry data showed that GATA6 expression levels in individual cells remained approximately constant in the presence of different doses of PD03, whereas the NANOG-Venus positive peak consistently shifted to higher expression levels with lowered signaling (Fig. 7C,D; Fig. S13). While not ruling out a more complex integration of FGF/MAPK signaling into the regulatory circuit underlying PrE-like differentiation, these results suggest that a major route by which FGF/MAPK signaling controls the fraction of cells with PrE-like differentiation is through inhibition of the Epi-specific gene expression program. This conclusion is further supported by a recent report showing direct inhibition of NANOG expression by FGF/MAPK signaling mediated by chromatin modifications (Hamilton and Brickman, 2014).
Finally, we sought to develop a visual representation of the system's dynamics in different signaling regimes by estimating the path-integral quasi-potential surfaces (Bhattacharya et al., 2011) of the system for two different signaling levels (Fig. 7E,F). This representation highlights two basins of attraction corresponding to the NANOG-positive state and the GATA-positive state, respectively. A reduction in signaling bends the ridge that separates the basins towards the GATA-positive state, making its basin of attraction narrower and shallower relative to that of the NANOG-positive state (Fig. 7E,F).
We conclude that a simple mutual repression circuit is sufficient to capture the dynamic hallmarks of the Epi-versus-PrE fate decision, and that through repression of the Epi program, FGF/MAPK signaling sets the relative sizes of the basins of attraction corresponding to the two fates defined by this circuit, allowing signaling to regulate the proportions of cells adopting either fate.
Here we have used engineered mouse ESC lines to study the mechanism underlying the decision between the Epi and the PrE fate. Our experimental system allowed us to modulate and measure quantitatively the transcription factor and signaling inputs into the decision, and to follow the dynamics of the decision at the level of single cells. We have uncovered two successive functions of MAPK signaling in the ESC system. Before the induced expression of GATA factors, inhibition of MAPK signaling is required to make the PrE-like differentiation program accessible in ESCs. Once exogenous GATA factors are expressed, MAPK signaling is required to execute the decision of PrE-like differentiation. The Epi-versus-PrE differentiation event displays hallmarks of an irreversible bistable switch, as co-expression of determinants of the Epi and the PrE fate resolves into one of two mutually exclusive stable states characterized by NANOG and GATA expression, respectively. We detect a well-defined threshold level of exogenous GATA factor expression required to flip this switch and induce differentiation, and find that MAPK signaling sets this threshold dose. This decision is therefore a strongly regulated process that is largely determined by few well-defined transcriptional and signaling inputs.
The accessibility of the PrE program depends on ESC culture conditions
We find that cells cultured in the presence of serum are refractory to PrE-like differentiation upon induced GATA expression, but responsiveness to doxycycline-induced GATA factors can be restored by extended exposure to GSK3 or MEK inhibitors, e.g. in 2i medium. One interpretation of this finding is that ESCs cultured in serum are strongly biased towards embryonic fates, and as a consequence have blocked the PrE-like differentiation program. In line with this idea, ESCs grown in the presence of serum display higher levels of repressive chromatin marks on a subset of promoters, including the Gata6 promoter, than cells grown in 2i+LIF (Marks et al., 2012). Furthermore, the transcriptome of ICM cells resembles more closely that of ESCs cultured in 2i medium than that of ESCs cultured in serum (Boroviak et al., 2014). This suggests that pre-culture in 2i brings ESCs to a molecular state mirroring that of early ICM cells, from which, upon induced GATA expression, the decision between the Epi and the PrE fate can be taken similarly to the situation in the embryo.
Extraembryonic fate choice is determined by the output of a simple mutual repression circuit
Our finding that precise measurements of GATA4-mCherry expression levels allow prediction of fate decisions in individual ESCs with high confidence before endogenous fate markers appear led us to formulate a minimal genetic circuit model with deterministic regulation to formalize the mechanism of the decision process. Our model solely consists of mutually repressive interactions between the Epi- and the PrE-like program, modulated by a repressive input of FGF/MAPK on the Epi program (Fig. 7B). This is sufficient to recapitulate the experimentally observed dynamics of lineage marker expression, to model bistable behavior, and to formalize our finding that the role of MAPK signaling is to set a GATA threshold required for PrE-like differentiation. Our minimal model is a subnetwork of a more complex model for the Epi-versus-PrE fate decision recently developed by Bessonnard et al. (2014). Bessonnard's model posits an additional positive input of FGF/MAPK signaling onto GATA expression, and contains positive autoregulatory feedback loops centered on both NANOG and GATA, which endow the dynamic system with a third stable state of NANOG and GATA co-expression. This allowed Bessonnard et al. to simulate both the establishment and the resolution of the co-expression state in a single model. Focusing on the resolution of the co-expression state, our data suggest that the additional links of Bessonnard's model are not required to explain the dynamics of this phase of the decision. It remains, however, possible that positive autoregulation of the Epi and PrE programs and a positive input of FGF/MAPK signaling on GATA expression fine-tune the response of cells during this stage of the decision process.
We note that not all cells abide by the GATA4-mCherry threshold that best predicts PrE-like differentiation. This might reflect persistent heterogeneous chromatin configurations that block PrE-like differentiation in individual cells, or be a consequence of heterogeneous MAPK signaling among ESCs. Signaling heterogeneities have been detected in other cell lines (Albeck et al., 2013; Aoki et al., 2013), and we expect they will be functionally relevant for PrE-like differentiation of ESCs.
Integration of signaling into the mutual repression circuit serves to balance proportions of cell fates in developing tissues
The mathematical model of a mutual repression circuit has previously been applied to describe the dynamics of the switch between the lysogenic and lytic phases of the lifecycle of bacteriophage lambda (Ptashne, 2004), and a genetically engineered toggle switch circuit in Escherichia coli (Gardner et al., 2000). Our work is one of the first experimentally supported examples demonstrating that this network can be used to formalize the decision between two fates during mammalian development. Extending the model with a signaling input allows for dynamic control of the sizes of the basins of attraction corresponding to the different states of the bistable system. The mammalian preimplantation embryo might harness this property to balance the proportion of Epi and PrE cells. The initial expression of transcriptional regulators driving lineage choice is stochastic, possibly as a consequence of the mechanisms that control gene expression in the early embryo (Dietrich and Hiiragi, 2007; Ohnishi et al., 2014). The resulting heterogeneous distributions of transcription factor concentrations will bias ICM cells towards specific fates (Xenopoulos et al., 2015). It has been shown that lineage commitment occurs non-synchronously in the cells of the ICM, and that the first cells to commit are fated towards the epiblast (Grabarek et al., 2012). Because Epi cells produce FGF4 (Frankenberg et al., 2011; Nichols et al., 1998), FGF4 levels will reflect the number of Epi-committed cells and act on the as yet uncommitted cells. By modulating the bistable switch operating in these cells, this process might ultimately place the appropriate number of uncommitted cells in the basin of attraction corresponding to the PrE fate. FGF/MAPK signaling might thus acts as a feedback mechanism to balance proportions of two distinct cell fates in populations (Lander et al., 2009). It will be interesting to see whether this new principle applies to differentiation decisions beyond those in the preimplantation embryo.
MATERIALS AND METHODS
ESC culture and genetic manipulation
For genetic engineering, ESCs were grown on mitotically inactivated mouse embryonic fibroblasts in Knockout DMEM (Gibco) supplemented with 15% fetal bovine serum (FBS), 50 µM β-mercaptoethanol, glutamax, non-essential amino acids and 1 µg/ml LIF. After line derivation, feeders were removed by serial passaging, and cells were maintained on gelatin-coated dishes in GMEM-based medium supplemented with 10% FBS, sodium pyruvate, 50 µM β-mercaptoethanol, glutamax, non-essential amino acids and LIF.
Serum-free media were based on N2B27 (NDiff 227, Stem Cells) and supplemented with 3 µM CHIR99021, 1 µM PD0325901 and 1 µg/ml LIF to give 2i+LIF. For the experiments described in Fig. S11, N2B27 was supplemented with 10 ng/ml BMP4 (R&D), 1 µg/ml LIF and 1 µg/ml heparin.
Cells for immunocytochemistry were grown on ibidi µ-slides and stained as described in Kalmar et al. (2009). Primary antibodies were anti-NANOG (1:200; eBiosciences, 14-5761), anti-FLAG (1:1000; Sigma M2, F3165), anti-GATA6 (1:200; R&D, AF1700) and anti-GATA4 (1:200; Santa Cruz, sc-9053). Detection was performed using Alexa Fluor-conjugated secondary antibodies at 4 μg/ml (Molecular Probes). Nuclei were visualized using Hoechst 33342 dye at 100 μg/ml (Molecular Probes, H1399). Cells were imaged on a Zeiss LSM700 confocal microscope with a 40× oil immersion lens (NA 1.3).
Cells for flow cytometry were trypsinized and either analyzed immediately or fixed for 15 min in 3% PFA/PBS. Intracellular antigens were stained in suspension using the same primary and secondary antibodies as used for immunostaining. mCherry fluorescence was measured on a BD Fortessa Flow cytometer, all other flow cytometric analysis was performed using a Beckman Coulter CyAn ADP analyzer. Cell sorting was done on a Beckman Coulter MoFlo. To estimate peak positions, histograms were smoothened, followed by detection of local maxima with custom-written Python scripts.
For immunoblotting, cells were lysed in RIPA buffer and lysates were separated on polyacrylamide gels before transfer to nitrocellulose membranes. Antibodies used were anti-ppErk (Sigma, M9692) and anti-Erk1/2 (Millipore, 06-182) at 1:500 dilution. Detection was performed using fluorescently labeled secondary antibodies at 0.1 μg/ml (LI-COR) and scanning in a LI-COR Odyssey system. Intensities of bands were quantified in ImageStudio (LI-COR).
Time-lapse imaging and cell tracking
Time-lapse imaging was performed in DMEM-based medium without Phenol Red, supplemented as detailed above. We used a Zeiss Axiovert M200 microscope equipped with a SOLA LED light source, an Andor iXON Ultra 888 EMCCD camera and a heated stage with CO2 supply. Hardware was controlled by MicroManager software (Edelstein et al., 2001). Time-lapse movies were acquired using a 40× long-working distance lens. See the supplementary materials and methods for details on image analysis.
We thank K. Niakan (The Francis Crick Institute) for providing cell lines; K. Anastassiadis (BIOTEC, TU Dresden), B. Rosen (Wellcome Trust Sanger Institute), C. Lindon (Department of Genetics, University of Cambridge) and A.-K. Hadjantonakis (Memorial Sloan Kettering Cancer Center) for sharing reporter constructs; L. Filipkova, N. S. Ly and R. Broome for technical assistance; L. Garcia-Perez, C. Vintiner and J. Padua for help with cell tracking; J. Nichols and A.-K. Hadjantonakis for insightful discussions; and C. Pina, J. de Navascués, S. Muñoz-Descalzo, C. Brimson, J. Garci-Ojalvo and A. Oates for helpful comments on earlier versions of this manuscript.
C.S., P.R. and A.M.A. conceived the study; C.S. performed experiments; C.S., P.R. and J.P.M. analyzed the data; P.R. developed the mathematical model; C.S. wrote the manuscript with input from P.R. and A.M.A.; all authors approved the manuscript.
Work in the A.M.A. lab was funded by the European Research Council [Grant Agreement 250316-MOFDH]; C.S. was the recipient of an EMBO long-term fellowship [ALTF 649-2011]; and C.S. and P.R. were supported by a Marie Curie fellowship [PIEF-GA-2011-299386 to C.S., PIEF-GA-2013-627124 to P.R.]. Deposited in PMC for immediate release.
The authors declare no competing or financial interests.